Multi-Specific Antibodies Market Size, Share, Emerging Trends and Forecast 2024-2030
The report " Multi-Specific Antibodies Market by Type (Bispecific Antibody, Tri specific Antibody, Tetra specific Antibody, Multi Specific Antibody), by Drug– (Multispecific (Amivantamab, Blinatumomab), Bispecific (Glofitamab, Epcoritamab, Mosunetuzumab, Teclistamab, Faricimab, Tebentafusp, Emicizumab)), by Indication (Autoimmune Disorders, Genetic Disorders, Haematological Malignancies, Ophthalmic Disorders, Skin Cancers, Solid Tumours), by End User (Hospital, Pharmacies, Others) - Global Forecasts to 2030"